Research study Program year 2020 Source: CMS Open Payments

M16-066

ClinicalTrials.gov NCT03398135

Research payments

$1,445,749

460 payments

Through program year 2020, $1,445,749 in research payments was reported against M16-066, across 460 payments, paid by AbbVie, Inc..

Paid by: AbbVie, Inc.
ClinicalTrials.gov: NCT03398135

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$905,260	308
2019	Research	$540,489	152

Breakdown

Who paid Research payments · program years 2019–2020

AbbVie, Inc. $1,445,749 460 payments

Who received the money Research payments · program years 2019–2020

Columbia University Med Center Organisation paid for research $206,125 35 payments
Vilo Research Group INC Organisation paid for research $104,883 23 payments
Tyler Research Institute LLC Organisation paid for research $99,298 18 payments
Cedars-Sinai Medical Center Teaching hospital · CA $82,585 17 payments
Avicenna Clinical Research LLC Organisation paid for research $60,743 19 payments
Digiovanna Family Care Organisation paid for research $56,437 16 payments
Mayo Clinic Health System Organisation paid for research $46,627 19 payments
Benaroya Research Institute at Virginia Mason Organisation paid for research $45,295 16 payments
Vanderbilt University Medical Center Teaching hospital · TN $35,254 22 payments
Southern California Liver Centers Organisation paid for research $32,803 15 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.